Written by Paula Hernández. It is crucial that Academia and Industry work in collaboration to keep the loop of Technology and Knowledge Transfer going. This was one of the core conclusions reached by the participants in the “Academia vs Industry” Round Table which took place last Wednesday 16th December as an exciting closing event of …
Read more “Highlights of the debate “Academia vs Industry”!”
Brief Introduction about yourself and the project (TATAMI) I am a scientific researcher looking for new therapeutic approaches for neuromuscular diseases. In this project particularly we are developing a novel therapeutic strategy for myotonic dystrophy based on blocking specific small RNAs or microRNA with antisense oligonucleotides, or anti-miRs. Tell us about you implication in the …
Read more “Dr. Juanma Fernández Costa, researcher working at the IBEC”
Brief Introduction about yourself and ARTHEx Biotech I have been working as a postdoctoral researcher in the department of Genetics in the University of Valencia, dedicated mainly to deciphering the pathomechanisms of Myotonic Dystrophy disease and finding new therapeutic targets for the disease. ARTHEx Biotech S.L is a spin-off company of the University of Valencia …
Read more “Interview with Dr. Beatriz Llamusí, CEO and co-founder of ARTHEx biotech”